Indivior Pharmaceuticals (INDV) Revenue (2024 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Revenue of $317.0 million for Q1 2026, up 19.17% year-over-year from $266.0 million in Q1 2025, and down 11.45% quarter-over-quarter from $358.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Revenue (2024 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Revenue history runs 3 years deep, the most recent figure standing at $317.0 million for Q1 2026.
- In Q1 2026, Revenue rose 19.17% year-over-year to $317.0 million; the TTM figure through Mar 2026 stood at $1.3 billion (up 10.25% YoY), while the FY2025 annual figure was $1.2 billion, up 4.29% from the prior year.
- Revenue for Q1 2026 stood at $317.0 million, down from $358.0 million in the prior quarter.
- The five-year high for Revenue was $358.0 million in Q4 2025, with the low at $266.0 million in Q1 2025.
- The 3-year median for Revenue is $302.0 million (2025), against an average of $305.1 million.
- Peak annual rise in Revenue reached 19.73% in 2025, while the deepest fall reached 6.34% in 2025.
- Indivior Pharmaceuticals' Revenue stood at $299.0 million in 2024, then rose by 19.73% to $358.0 million in 2025, then fell by 11.45% to $317.0 million in 2026.
- Business Quant data shows INDV's Revenue at $317.0 million in Q1 2026, $358.0 million in Q4 2025, and $314.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.60 Bn | 4.37 Bn | 294.00 Mn | 343.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 343.00 Mn |
| Mar 31, 2026 | 317.00 Mn |
| Dec 31, 2025 | 358.00 Mn |
| Sep 30, 2025 | 314.00 Mn |
| Jun 30, 2025 | 302.00 Mn |
| Mar 31, 2025 | 266.00 Mn |
| Dec 31, 2024 | 299.00 Mn |
| Sep 30, 2024 | 307.00 Mn |
| Jun 30, 2024 | 299.00 Mn |
| Mar 31, 2024 | 284.00 Mn |